Grantham, Mayo, Van Otterloo & Co (GMO)
OVV icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Ovintiv OVV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OVV Stock Details OVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,174,000
Closed -$33.9M – 734
2018
Q4 		$33.9M Buy
+1,174,000
New +$50.6M 0.27% 70

Other funds holding OVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s OVV Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Ovintiv (OVV) stake by 56% in Q1 2026, buying an estimated $1.7M and bringing the position to 98,900 shares worth $5.87M. The position accounts for 0.02% of the portfolio, ranked #300.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OVV in Q2 2013 and has held it in 17 quarters since. The position peaked at $39M in Q3 2023. 610 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 98,900 shares of Ovintiv worth $5.87M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 35,300 Ovintiv shares in Q1 2026, an estimated $1.7M.
  • Ovintiv made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #300 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ovintiv in Q2 2013 and has held it in 17 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ovintiv position peaked at $39M in Q3 2023.
  • 610 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.